Monocomponent insulins
Rodríguez-Miñón, J.L.
Minerva Medica 68(35): 2485-2490
1977
ISSN/ISBN: 0026-4806 PMID: 887227 Document Number: 124196
Document emailed within 1 workday
Related Documents
Johnson, Z.; McDonnell, J.; Devlin, J.G. 1984: Comparison of purified bovine and monocomponent porcine insulins Irish Medical Journal 77(12): 380Fagerberg, S.E.; Gamstedt, A. 1976: Experiences with monocomponent insulin Lakartidningen 73(47): 4097-4099
Korp, W.; Levett, R.E. 1973: Experiences with monocomponent insulin treatment Wiener Klinische Wochenschrift 85(18): 326-330
Rodriguez-Miñon, J.L.; Rios, M.S. 1978: Monocomponent insulin: general considerations Journees Annuelles de Diabetologie de l'Hotel-Dieu 1978: 109-122
Devlin, J.G.; Parameswaran, V. 1978: Characterisation of antibody response to monocomponent insulin Irish Medical Journal 71(8): 256-260
Mohan, V.; Shyamsundar, R.; Ramachandran, A.; Viswanathan, M.; Snehalatha, C. 1983: Allergy to monocomponent porcine and human insulin Journal of the Association of Physicians of India 31(11): 721-722
Iafusco, D. 2003: New insulins and quality of life Acta Bio-Medica: Atenei Parmensis 74(Suppl 1): 18-20
Viswanathan, M.; Ramachandran, A.; Snehalatha, C.; Viswanathan, M. 1981: Monocomponent insulin in maturity onset diabetes mellitus Journal of the Indian Medical Association 76(5): 73-75
Hale, D.E.; Kiess, W. 2004: Insulins and oral hypoglycemic medications Pediatric Endocrinology Reviews: Per 2(Suppl 1): 153-162
Sheldon, J. 1985: Insulin syringes and the changeover to U. 100 insulins Diabetic Medicine: a Journal of the British Diabetic Association 2(1): 66
Bilo, H.J.; Heine, R.J.; Sikkenk, A.C.; van der Meer, J.; van der Veen, E.A. 1985: Kinetics of intermediate-acting insulins: clamp studies Netherlands Journal of Medicine 28(Suppl): 55-56
Perlemuter, L. 1988: Insulin of man and human insulins. Medical and economic aspects in 1987 Presse Medicale 17(8): 361-363
van der Veen, E.A.; Heine, R.J.; van der Meer, J. 1986: Recombinant DNA insulins and diabetes mellitus. Short review and perspective Netherlands Journal of Medicine 29(2): 62-64
Cockram, C.S.; Jones, R.H.; Sönksen, P.H. 1985: The biological properties of insulins with tyrosine replaced by phenylalanine at positions 14 and 19 of the a chain Diabetic Medicine: a Journal of the British Diabetic Association 2(4): 241-244
Reid, T.S.; White, J.; Meneghini, L. 2019: The Relevance of Clinical Pharmacology Studies of Basal Insulins to Primary Care Journal of Family Practice 68(1 Suppl)
Cholewka, W.; Cieszyńska, E. 1981: Radioimmunological method of determination of glucagon content in insulins of Polish production Acta Poloniae Pharmaceutica 38(1): 139-140
Harrower, A.D.; Duncan, L.J.; Clarke, B.F. 1975: Comparison of injection techniques for soluble and protamine zinc insulins in diabetes mellitus Practitioner 214(1280): 228-231
Bottermann, P. 1999: Practice tips for modern insulin therapy. "Bed time insulins without adverse morning aftereffect" MMW Fortschritte der Medizin 141(48): 40-42
Renner, R. 2000: New trend in type 2 diabetes moves toward short-term insulins! Better metabolic control, less weight gain MMW Fortschritte der Medizin 142(21): 30-32
Piers, D.A.; Sluiter, W.J.; Reitsma, W.D.; Doorenbos, H. 1974: Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin Netherlands Journal of Medicine 17(4-5): 234-238